Format

Send to

Choose Destination
J Allergy Clin Immunol Pract. 2019 Oct 31. pii: S2213-2198(19)30909-2. doi: 10.1016/j.jaip.2019.10.018. [Epub ahead of print]

High-dose omalizumab use in patients with chronic spontaneous urticaria.

Author information

1
Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Electronic address: m.alizadehaghdam@umcutrecht.nl.
2
Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
PMID:
31678293
DOI:
10.1016/j.jaip.2019.10.018

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center